"Then we go alone" Not an unrealistic suggestion Leppo. When we look at the team, the facilities, and the connections that the CEO has put together, including the professional Board of Directors, the experienced staff including the recent engineering appointment, the highly qualified Advisory Body, the surgeons who have been involved in the early feasibility, the liasion with major hospitals, the expanded manufacturing facilities in Minneapolis plus the facility at Malaga he certainly has all the ingredients to go it alone. Would just need a lot more cash to make it happen but if it did it would not just be aortic valves that would be developed - there are a number of other projects sitting on the back burner whilst they concentrate on DurAVR and ComASUR. When I hear the CEO give presentations and interviews I always think to myself - this person is building an empire. I hope he succeeds. It would probably then take a bit longer for shareholders to realize the returns that we are expecting. Would it be worth the wait?
AVR Price at posting:
$16.50 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)